로딩 중…
지수 로딩 중…
Enanta Pharmaceuticals, Inc.
ENTA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$12.66+0.16%
2026-06-18
Price Chart
Enanta Pharmaceuticals, Inc.+75.10%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $368M |
| Revenue | $69M |
| Net Income | $-62M |
| Total Assets | $315M |
| Net Assets | $117M |
| Value | |
| P/B | 3.16x |
| P/S | 5.32x |
| FCF Yield | -2.61% |
| Profitability | |
| ROE | -53.17% |
| ROA | -19.70% |
| Op. Margin | -87.24% |
| Revenue Growth | 14.96% |
| Financial Health | |
| Debt Ratio | 169.93% |
| Total Debt | $187M |
| FCF | $-10M |
| Cash | $35M |
| Current Ratio | 3.84x |
| Performance | |
| 1Y Return | 75.10% |
| 1M Return | -7.99% |
| From 52W High | -26.18% |
| 1Y MDD | -34.30% |
| Trading | |
| Volume | 245,123 shares |
| Trading Value | $3M |
| Per Share | |
| EPS | $-3.35 |
| BPS | $5.92 |